Search Results - "Moscovici, A."

Refine Results
  1. 1
  2. 2

    2.5 million hectares and one sustainable goal by Moscovici, Daniel A

    “…Purpose - The purpose of this paper is to investigate historical environmental destruction and subsequent land use policies enacted over the last 400 years in…”
    Get full text
    Journal Article
  3. 3

    The role of calcimimetics in chronic kidney disease by Gal-Moscovici, A., Sprague, S.M.

    Published in Kidney international (01-12-2006)
    “…Secondary hyperparathyroidism (SHPT) develops in chronic kidney disease as a consequence of impaired phosphate, calcium, and vitamin D homeostasis. Treatment…”
    Get full text
    Journal Article
  4. 4

    New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels by Gal-Moscovici, A, Popovtzer, M M

    Published in Clinical nephrology (01-04-2005)
    “…Abnormal mineral metabolism in chronic renal disease is associated with bone disease and extraskeletal calcifications. High turnover, hyperparathyroid bone…”
    Get more information
    Journal Article
  5. 5

    Evidence of a parathyroid hormone-independent chronic effect of estrogen on renal phosphate handling and sodium-dependent phosphate cotransporter type IIa expression by Guttmann-Rubinstein, L, Lichtstein, D, Ilani, A, Gal-Moscovici, A, Scherzer, P, Rubinger, D

    Published in Hormone and metabolic research (01-04-2010)
    “…The effects of estrogen on phosphate metabolism are not well understood. To better define the chronic effects of estrogen on phosphate balance and on renal…”
    Get more information
    Journal Article
  6. 6

    Treatment of osteoporotic ovariectomized rats with 24,25(OH)2D3 by Gal-Moscovici, A., Gal, M., Popovtzer, M. M.

    Published in European journal of clinical investigation (01-06-2005)
    “…Background  Antiresorptive therapeutic regimens are the mainstay of current management of osteoporosis. Treatments that are promoting new bone formation are…”
    Get full text
    Journal Article
  7. 7

    Stimulation of osteoclastic bone resorption in a model of glycerol-induced acute renal failure: evidence for a parathyroid hormone-independent mechanism by Gal-Moscovici, A, Scherzer, P, Rubinger, D, Weiss, R, Dranitzki-Elhalel, M, Popovtzer, M.M

    Published in Bone (New York, N.Y.) (01-10-2002)
    “…This study was undertaken to evaluate the bone changes occurring in rats with acute renal failure (ARF). Acute renal failure was induced in rats 24 hours after…”
    Get full text
    Journal Article
  8. 8
  9. 9

    24,25-dihydroxyvitamin D3 in combination with 1,25-dihydroxyvitamin D3 ameliorates renal osteodystrophy in rats with chronic renal failure by Gal-Moscovici, A, Rubinger, D, Popovtzer, M M

    Published in Clinical nephrology (01-05-2000)
    “…This study compares the effects of 1,25(OH)2D3 and 24,25(OH)2D3 alone or in combination on renal osteodystrophy in rats with chronic renal failure (CRF). One…”
    Get more information
    Journal Article
  10. 10

    Renal osteodystrophy in rats with reduced renal mass by MOSCOVICI, A, BERNHEIM, J, POPOVTZER, M. M, RUBINGER, D

    “…The rat remnant kidney, a popular model of experimental renal failure, has also been used to assess the histological bone changes associated with reduction in…”
    Get full text
    Conference Proceeding Journal Article
  11. 11

    Role of Vitamin D Deficiency in Chronic Kidney Disease by Gal‐Moscovici, Anca, Sprague, Stuart M

    Published in Journal of bone and mineral research (01-12-2007)
    “…Chronic kidney disease (CKD) has been recognized as a significant public health problem, with ∼20 million Americans, or ∼11% of the adult population, currently…”
    Get full text
    Journal Article Conference Proceeding
  12. 12
  13. 13
  14. 14

    Treatment of osteoporotic ovariectomized rats with 24,25(OH) 2 D 3 by Gal‐Moscovici, A., Gal, M., Popovtzer, M. M.

    Published in European journal of clinical investigation (01-06-2005)
    “…Abstract Background  Antiresorptive therapeutic regimens are the mainstay of current management of osteoporosis. Treatments that are promoting new bone…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Treatment of osteoporotic ovariectomized rats with 24,25(OH) sub(2)D sub(3) by Gal-Moscovici, A, Gal, M, Popovtzer, M M

    Published in European journal of clinical investigation (01-06-2005)
    “…Background: Antiresorptive therapeutic regimens are the mainstay of current management of osteoporosis. Treatments that are promoting new bone formation are…”
    Get full text
    Journal Article
  17. 17

    Parathyroid hormone‐independent osteoclastic resorptive bone disease: a new variant of adynamic bone disease in haemodialysis patients by Gal‐Moscovici, Anca, Popovtzer, Mordecai M.

    Published in Nephrology, dialysis, transplantation (01-04-2002)
    “…Background. Osteitis fibrosa cystica (OFC) caused by secondary hyperparathyroidism is the pre‐eminent form of uraemic osteodystrophy. In recent years, however,…”
    Get full text
    Journal Article
  18. 18

    Regulation of NaPi-IIa mRNA and transporter protein in chronic renal failure: role of parathyroid hormone (PTH) and dietary phosphate (Pi) by Elhalel, Michal Dranitzki, Wald, Hanna, Rubinger, Dvora, Gal-Moscovici, Anka, Inoue, Makoto, Levi, Moshe, Popovtzer, Mordecai M

    Published in Pflügers Archiv (01-12-2004)
    “…Chronic renal failure (CRF) is associated with a high fractional phosphate excretion (FEPi), secondary hyperparathyroidism, and resistance to parathyroid…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Land preservation's link to the environment, economy, and society in the Northern Forest of Maine, New Hampshire, Vermont and the Adirondack region of New York by Moscovici, Daniel A

    Published 01-01-2009
    “…The Northern Forest remains one of the last intact, privately owned forests in the United States. Rural areas of northern Maine, New Hampshire, Vermont, and…”
    Get full text
    Dissertation